NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Report
Lupin Ltd. delivered a strong set of June-quarter earnings, beating both brokerage and Street estimates across revenue, Ebitda and profit. However, Systematix retained its 'Hold' rating on the pharmaceutical company, citing intensifying competition in the US market that could weigh on growth and margins in the coming quarters.
The brokerage has a target price of Rs 2,284 on the stock.
Lupin reported revenue of Rs 8,277 crore in Q1 FY27, up 32% YoY and 6.9% above Systematix's estimates. Ebitda climbed 50% YoY to Rs 2,463 crore, while profit after tax rose 16% to Rs 1,415 crore, exceeding both brokerage and consensus estimates. EBITDA margin expanded to 29.8% during the quarter.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
